Intercellular Spread of Protein Aggregates in Neurodegenerative Disease

被引:92
作者
Davis, Albert A. [1 ,2 ]
Leyns, Cheryl E. G. [1 ,2 ,3 ]
Holtzman, David M. [1 ,2 ,3 ]
机构
[1] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Knight Alzheimers Dis Res Ctr, St Louis, MO 63110 USA
来源
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 34 | 2018年 / 34卷
关键词
neurodegenerative disease; protein aggregate; seeding; spreading; PATHOLOGICAL ALPHA-SYNUCLEIN; FRONTOTEMPORAL LOBAR DEGENERATION; AMYOTROPHIC-LATERAL-SCLEROSIS; PRION-LIKE PROPAGATION; ALZHEIMERS-DISEASE; TUNNELING NANOTUBES; MUTANT HUNTINGTIN; TAU PATHOLOGY; MOUSE MODEL; REGIONAL VULNERABILITY;
D O I
10.1146/annurev-cellbio-100617-062636
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Most neurodegenerative diseases are characterized by the accumulation of protein aggregates, some of which are toxic to cells. Mounting evidence demonstrates that in several diseases, protein aggregates can pass from neuron to neuron along connected networks, although the role of this spreading phenomenon in disease pathogenesis is not completely understood. Here we briefly review the molecular and histopathological features of protein aggregation in neurodegenerative disease, we summarize the evidence for release of proteins from donor cells into the extracellular space, and we highlight some other mechanisms by which protein aggregates might be transmitted to recipient cells. We also discuss the evidence that supports a role for spreading of protein aggregates in neurodegenerative disease pathogenesis and some limitations of this model. Finally, we consider potential therapeutic strategies to target spreading of protein aggregates in the treatment of neurodegenerative diseases.
引用
收藏
页码:545 / 568
页数:24
相关论文
共 171 条
  • [21] The pathological process underlying Alzheimer's disease in individuals under thirty
    Braak, Heiko
    Del Tredici, Kelly
    [J]. ACTA NEUROPATHOLOGICA, 2011, 121 (02) : 171 - 181
  • [22] Stages of pTDP-43 Pathology in Amyotrophic Lateral Sclerosis
    Brettschneider, Johannes
    Del Tredici, Kelly
    Toledo, Jon B.
    Robinson, John L.
    Irwin, David J.
    Grossman, Murray
    Suh, EunRan
    Van Deerlin, Vivianna M.
    Wood, Elisabeth M.
    Baek, Young
    Kwong, Linda
    Lee, Edward B.
    Elman, Lauren
    McCluskey, Leo
    Fang, Lubin
    Feldengut, Simone
    Ludolph, Albert C.
    Lee, Virginia M. -Y.
    Braak, Heiko
    Trojanowski, John Q.
    [J]. ANNALS OF NEUROLOGY, 2013, 74 (01) : 20 - 38
  • [23] Non-canonical soluble amyloid-beta aggregates and plaque buffering: controversies and future directions for target discovery in Alzheimer's disease
    Brody, David L.
    Jiang, Hao
    Wildburger, Norelle
    Esparza, Thomas J.
    [J]. ALZHEIMERS RESEARCH & THERAPY, 2017, 9
  • [24] Localization of a toxic form of superoxide dismutase 1 protein to pathologically affected tissues in familial ALS
    Brotherton, Terrell E.
    Li, Yingjie
    Cooper, Deborah
    Gearing, Marla
    Julien, Jean-Pierre
    Rothstein, Jeffrey D.
    Boylan, Kevin
    Glass, Jonathan D.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (14) : 5505 - 5510
  • [25] Molecular, structural, and functional characterization of Alzheimer's disease: Evidence for a relationship between default activity, amyloid, and memory
    Buckner, RL
    Snyder, AZ
    Shannon, BJ
    LaRossa, G
    Sachs, R
    Fotenos, AF
    Sheline, YI
    Klunk, WE
    Mathis, CA
    Morris, JC
    Mintun, MA
    [J]. JOURNAL OF NEUROSCIENCE, 2005, 25 (34) : 7709 - 7717
  • [26] Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade
    Chiti, Fabrizio
    Dobson, Christopher M.
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, VOL 86, 2017, 86 : 27 - 68
  • [27] Mutant Huntingtin is Present in Neuronal Grafts in Huntington Disease Patients
    Cicchetti, Francesca
    Lacroix, Steve
    Cisbani, Giulia
    Vallieres, Nicolas
    Saint-Pierre, Martine
    St-Amour, Isabelle
    Tolouei, Ranna
    Skepper, Jeremy N.
    Hauser, Robert A.
    Mantovani, Diego
    Barker, Roger A.
    Freeman, Thomas B.
    [J]. ANNALS OF NEUROLOGY, 2014, 76 (01) : 31 - 42
  • [28] Synaptic activity regulates interstitial fluid amyloid-β levels in vivo
    Cirrito, JR
    Yamada, KA
    Finn, MB
    Sloviter, RS
    Bales, KR
    May, PC
    Schoepp, DD
    Paul, SM
    Mennerick, S
    Holtzman, DM
    [J]. NEURON, 2005, 48 (06) : 913 - 922
  • [29] The most prevalent genetic cause of ALS-FTD, C9orf72 synergizes the toxicity of ATXN2 intermediate polyglutamine repeats through the autophagy pathway
    Ciura, Sorana
    Sellier, Chantal
    Campanari, Maria-Letizia
    Charlet-Berguerand, Nicolas
    Kabashi, Edor
    [J]. AUTOPHAGY, 2016, 12 (08) : 1406 - 1408
  • [30] Transmission and spreading of tauopathy in transgenic mouse brain
    Clavaguera, Florence
    Bolmont, Tristan
    Crowther, R. Anthony
    Abramowski, Dorothee
    Frank, Stephan
    Probst, Alphonse
    Fraser, Graham
    Stalder, Anna K.
    Beibel, Martin
    Staufenbiel, Matthias
    Jucker, Mathias
    Goedert, Michel
    Tolnay, Markus
    [J]. NATURE CELL BIOLOGY, 2009, 11 (07) : 909 - U325